ArticleCancer chemotherapy and pharmacology2018

A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies.

James J Harding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.